Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA066037-02
Application #
2109265
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1995-01-03
Project End
1999-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Surgery
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Cristiano, R J (1998) Viral and non-viral vectors for cancer gene therapy. Anticancer Res 18:3241-5
Cristiano, R J (1998) Targeted, non-viral gene delivery for cancer gene therapy. Front Biosci 3:D1161-70
Xu, B; Wiehle, S; Roth, J A et al. (1998) The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther 5:1235-43
Cristiano, R J; Xu, B; Nguyen, D et al. (1998) Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect Prev 22:445-54
Nguyen, D M; Wiehle, S A; Koch, P E et al. (1997) Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Ther 4:191-8
Nguyen, D M; Wiehle, S A; Roth, J A et al. (1997) Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex. Cancer Gene Ther 4:183-90
Roth, J A; Cristiano, R J (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21-39
Cristiano, R J; Roth, J A (1996) Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 3:4-10
Nguyen, D M; Spitz, F R; Yen, N et al. (1996) Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J Thorac Cardiovasc Surg 112:1372-6;discussion 1376-7